To understand the possible contribution of metabotropic g-aminobutyric acid receptors (GABA B R) in cortical development, we investigated the expression pattern and the cellular and subcellular localization of the GABA B R1 and GABA B R2 subtypes in the rat neocortex from embryonic day 14 (E14) to adulthood. At the light microscopic level, both GABA B R1 and GABA B R2 were detected as early as E14. During prenatal development, both subtypes were expressed highly in the cortical plate. Using double immuno¯uorescence, GABA B R1 colocalized with GABA B R2 in neurons of the marginal zone and subplate, indicating that these proteins are coexpressed and could be forming functional GABA B Rs during prenatal development in vivo. In contrast, only GABA B R1 but not GABA B R2 was detected in the tangentially migratory cells in the lower intermediate zone. During postnatal development, immunoreactivity for GABA B R1 and GABA B R2 was distributed mainly in pyramidal cells. Discrete GABA B R1-immunopositive cell bodies of interneurons were present throughout the neocortex. In addition, GABA B R1 but not GABA B R2 was found in identi®ed Cajal-Retzius cells in layer I. At the electron microscopic level, immunoreactivity for GABA B R1 and GABA B R2 was found in dendritic spines and dendritic shafts at extrasynaptic and perisynaptic sites throughout postnatal development. We further demonstrated the presynaptic localization of GABA B R1 and GABA B R2, as well as the association of the receptors with asymmetrical synaptic junctions. These results indicate potentially important roles for the GABA B Rs in the regulation of migratory processes during corticogenesis and in the modulation of synaptic transmission during early development of cortical circuitry.
Introduction g-Aminobutyric acid (GABA) is the main inhibitory neurotransmitter in the cerebral cortex. The response to GABA is mediated via activation of both ionotropic and metabotropic receptors (Macdonald & Olsen, 1994; Misgeld et al., 1995) . Metabotropic GABA receptors (GABA B Rs) are coupled to intracellular signal transduction mechanisms via G-proteins and mediate slow inhibitory postsynaptic potentials (Misgeld et al., 1995) . Activation of GABA B Rs can modulate multiple signal transduction pathways, mainly activating K + channels, inhibiting voltagedependent Ca 2+ channels, stimulating phospholipase A2, inhibiting adenylate cyclase and regulating inositol phospholipid hydrolysis (Misgeld et al., 1995) .
Two different cDNAs encoding GABA B Rs have been cloned to date: GABA B R1, which exist in alternatively spliced forms designated R1a±e, and GABA B R2 (Bowery & Brown, 1997; Kaupmann et al., 1997 Kaupmann et al., , 1998a Isomoto et al., 1998; Pfaff et al., 1999; Schwarz et al., 2000) . It has been suggested that heterodimeric assembly of GABA B R1a/b and GABA B R2 subtypes is required to provide fully functional receptors (Jones et al., 1998; Kaupmann et al., 1998a; White et al., 1998; Kuner et al., 1999) .
Light microscopic immunocytochemistry, in situ hybridization and receptor autoradiographic studies have shown that GABA B Rs are abundant in the cerebral cortex of adult animals (Bowery et al., 1987; Chu et al., 1990; Turgeon & Albin, 1994; Kaupmann et al., 1997; Bischoff et al., 1999; Margeta-Mitrovic et al., 1999; Mun Äoz et al., 2001) . Electron microscopic studies revealed that GABA B Rs are present in both excitatory and inhibitory synapses and also located outside the synaptic membrane specialization, at both postsynaptic and presynaptic locations (Gonchar et al., 2001; Kulik et al., 2002) . Electrophysiological and pharmacological studies have also characterized pre-and postsynaptic inhibitory functions of GABA B Rs in the neocortex (Howe et al., 1987; Deisz et al., 1993 Deisz et al., , 1997 Varela et al., 1997) . Presynaptic GABA B Rs are thought to suppress neurotransmitter release by depressing Ca 2+ in¯ux via voltage-activated Ca 2+ channels, whereas postsynaptic GABA B Rs decrease neuronal excitability by activating an inwardly rectifying K + (Kir3) conductance (Kaupmann et al., 1998b) .
Little information is available about the expression of GABA B Rs in the developing neocortex. Nevertheless, several lines of evidence suggest that GABA B R play important roles during cortical development. First, GABA B Rs modulate the excitatory actions of glutamate in developing cortical neurons through the regulation of glutamateactivated calcium transients (Obrietan & van den Pol, 1999) and second, speci®c GABA B R agonists stimulated migration of neurons (Behar et al., 1998) , whereas speci®c antagonists inhibited migration (Behar et al., 2000) .
Information regarding the distribution of GABA B Rs in the cerebral cortex is a prerequisite for studies designed to elucidate the contribution of GABA B Rs to developmental processes and to cortical function. However, the distribution and localization of GABA B R subtypes during corticogenesis are incompletely characterized. To better understand the mechanisms by which GABA B Rs mediate the physiological effects of GABA on developing cortical neurons, the goal of the present study was to characterize the expression pattern, and the cellular and the precise subcellular localization of GABA B R1 and GABA B R2 in the rat neocortex during pre-and postnatal development.
Thirty-nine Wistar rats from embryonic day 14 (E14) to adulthood, obtained from the Animal House Facilities of the University Miguel Herna Ândez in Alicante and the Department of Human Anatomy and Genetics in Oxford were used in the present study. The care and handling of the animals prior to and during the experimental procedures followed European Union and UK Home Of®ce regulations, and were approved by the Animal Care and Use Committees of the authors' institutions.
For each developmental stage, the animals used (n = 3 for each stage) were from different litters and were grouped as follows: E14, E16, E18, postnatal day 0 (P0, day of birth), P3, P5, P7, P10, P12, P15, P21, P30 and P60.
Antibodies and controls
Af®nity-puri®ed polyclonal antibodies against GABA B R1a/b and GABA B R2 were raised in rabbits and guinea pig, respectively. The characteristics and speci®city of the antibody against GABA B R1/b have been described elsewhere (Kulik et al., 2002) . The antibody against GABA B R2 was obtained from Chemicon (Temecula, CA, USA). To identify neuronal populations during cortical development, we used a monoclonal antibody, G10, against Reelin (De Bergeyck et al., 1998) gift of Dr A.M. Gof®net (Neurobiology Unit, University of Namur School of Medicine, Belgium), a monoclonal antibody, 12E3, against PSA-NCAM protein (the polysialylised form of the neuronal cell adhesion molecule NCAM; Seki and Arai, 1991) , gift of Dr Tatsunori Seki (Department of Anatomy, Juntendo University School of Medicine, Tokyo, Japan), and a monoclonal antibody against calbindin (Chemicon, Temecula, CA, USA).
To test method speci®city in the procedures for light and electron microscopy, the primary antibody was omitted or replaced with 5% (v/v) normal serum of the species of the primary antibody. Under these conditions, no selective labelling was observed. Staining patterns were also compared to those obtained by calretinin and calbindin (Chemicon, Temecula, CA, USA); only the antibodies against GABA B R1 and GABA B R2 labelled consistently the plasma membrane of cells. When double labelling was used, some sections were always incubated with only one primary antibody and the full complement of secondary antibodies to test for any cross-reactivity.
Other sections were incubated with two primary antibodies and one secondary antibody, followed by the full sequence of signal detection. No cross-labelling was detected that would in¯uence the results.
Immunocytochemistry for metabotropic GABA receptors

Light microscopic procedures
Fetuses were collected by caesarean section after anaesthesia of the dam with an intraperitoneal (i.p) injection of a Rompun± Imalgene mixture (0.1 mL/kg body weight). Animals were deeply anaesthetized by hypothermia (E14 to P5) or by i.p. injection of Rompun±Imalgene (1 : 1, 0.1 mL/kg body weight) and then the hearts were exposed surgically for perfusion ®xation (Lo Âpez-Bendito et al., 2001 . After perfusion, tissue blocks containing the neocortex were dissected and washed thoroughly in 0.1 M phosphate buffer (PB, pH 7.4). Coronal, 60 mm sections were cut with a Vibratome and collected in 0.1 M PB. For the immunoperoxidase method, sections were incubated in 10% normal goat serum (NGS) in 50 mM Tris buffer (pH 7.4) containing 0.9% NaCl (TBS), with 0.2% Triton X-100, for 1 hour. Sections were then incubated for 48 hours with af®nity-puri®ed polyclonal antibodies against GABA B R1a/b or GABA B R2 at a ®nal protein concentration of 1±2 mg/mL in TBS containing 1% NGS. After washes in TBS, the sections were incubated for 2 hours in biotinylated goat anti-rabbit IgG (Vector Laboratories, Burlingame, CA, USA) diluted 1 : 50 in TBS containing 1% NGS. They were then transferred into avidin±biotin±peroxidase complex (ABC kit, Vector Laboratories, Burlingame, CA, USA) diluted 1 : 100 and left for 2 hours at room temperature. Peroxidase enzyme activity was revealed using 3,3¢-diaminobenzidine tetrahydrochloride (DAB; 0.05% in TB, pH 7.4) as the chromogen and 0.01% H 2 O 2 as substrate. Finally, the sections were air-dried and coverslipped prior to observation with a Leica DMRS photomicroscope equipped with differential interference contrast optics.
Alternate sections were used for immuno¯uorescence experiments using a laser scanning confocal microscope (Leica TSLCM, Austria). Primary antibodies used in combination with a polyclonal antibody against GABA B R1 were: guinea pig polyclonal anti-GABA B R2; monoclonal anti-PSA-NCAM, diluted 1 : 1000; monoclonal anti-Reelin antibody, G10, diluted 1 : 1000 and monoclonal anti-calbindin antibody diluted 1 : 1000. Sections were incubated overnight at 4°C in a mixture of primary antibodies in TBS containing 1% NGS and 0.1% Triton X-100. Sections were then washed in TBS and incubated for two hours in a mixture of secondary antibodies coupled to the cyaninederived¯uorochromes Cy2 or Cy3 (Amersham, UK). These secondary antibodies were used at a dilution of 1 : 200 in TBS with 0.1% Triton X-100. After extensive TBS washes, the sections were mounted on gelatinized slides and coverslipped with Vectashield (Vector Laboratories, Burlingame, CA, USA).
Each labelling combination was analysed in sections from two to four prenatal or postnatal animals. Co-localization of GABA B R1 with GABA B R2 or with the neurochemical markers Reelin and calbindin was assessed by confocal laser microscopy (Leica TLSCM, Austria). For each marker, a semiquantitative estimation of the proportion of double labelled neurons was performed by analysing samples of 120± 160 cells, collected in 8±10 coronal sections through the neocortex. Images were stored digitally and analysed using appropriate software supplied by the microscope manufacturer. Brightness and contrast were adjusted for the whole frame; no part of a frame was enhanced or modi®ed in any way.
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Electron microscopic procedures
A similar procedure to that described earlier (Lo Âpez-Bendito et al., 2001 was used.
Pre-embedding immunoperoxidase and immunogold methods. Immunocytochemical reactions for the pre-embedding method were carried out as described above, but with the omission of Triton X-100 in all steps. Sections for the pre-embedding immunogold method were incubated together with those used for peroxidase reaction up to the secondary antibody stage. They were then incubated in goat anti-rabbit or goat anti-guinea pig IgG coupled to 1.4 nm gold particles (Nanoprobes Inc., Stony Brook, NY) diluted 1 : 100 in TBS containing 1% NGS. After several washes in phosphate-buffered saline (PBS), the sections were post®xed in 1% glutaraldehyde dissolved in the same buffer. They were washed in double distilled water, followed by silver enhancement of the gold particles with an HQ Silver kit (Nanoprobes Inc., Stony Brook, NY).
The peroxidase-reacted sections and the gold±silver-labelled sections were treated with OsO 4 (1% in 0.1 M PB), block-stained with uranyl acetate, dehydrated in graded series of ethanol and¯at-embedded on glass slides in Durcupan (Fluka, Reidel-deHae Èn, UK) resin. Regions of interest were cut at 70±90-nm-thick sections using an ultramicrotome (Reichert Ultracut E, Leica, Austria). Ultrathin sections were contrasted and analysed in a Jeol-100 electron microscope.
Results
Expression of GABA B Rs during prenatal development
To study the tissue expression of GABA B Rs during prenatal cortical development we carried out pre-embedding immunohistochemical studies at different ages.
GABA B R1
At E14, GABA B R1 immunoreactivity was detected in cells bodies located in the mantle layer of the septal and ganglionic eminences (Fig. 1A±D ). The intensity of immunoreactivity was strongest at the palaeocortical primordium, at the surface of the lateral and medial ganglionic eminences. Immunoreactivity at the neocortical primordium was less intense (Fig. 1C) . The receptor expression level increased with development. Thus, at E16 we found strong immunoreactivity for GABA B R1 in the habenula, dorsal thalamus, thalamic eminence, hypothalamus, in a circumscribed area surrounding the forming internal capsule and in the marginal zone (MZ) of the neocortical primordia (Fig. 1E) . In the MZ, we could distinguish at least two populations of cells immunoreactive for GABA B R1: large rounded cells located deeply in that layer, and super®cial cells running horizontally (Fig. 1H ). In the neocortical primordium, the cortical plate (CP) and the subplate (SP) were also immunoreactive ( Fig. 1E±G ). In addition, GABA B R1 immunoreactivity was also present in the tangential migratory cells in the intermediate zone ( Fig. 1G and I ).
At E18 we found increased levels of GABA B R1 immunoreactivity in the same regions as in previous ages (Fig. 1J±L) . Immunoreactivity in the CP was observed in apical dendrites of SP neurons or in ascendent or descendent ®bres running in this zone (Fig. 1K and L) . GABA B R1 immunoreactivity was also present in axons running in the intermediate zone, just below the SP (see Fig. 1K and L).
GABA B R2
At E14, GABA B R2 immunoreactivity was found at very low levels in most telencephalic areas ( Fig. 2A) , though it was intense in cells localized in the preplate (PP, Fig. 2A and B). The receptor expression level increased with development. Thus, at E16 we found strong GABA B R2 immunoreactivity in the neocortical MZ, CP and SP (Fig. 2C±E ). In addition, we observed immunolabelled axons in the intermediate zone, as well as numerous immunopositive processes in the ventricular zone (VZ, Fig. 2D and C). However, we did not detect GABA B R2 immunoreactivity in cell bodies of tangentially migratory neurons in the intermediate zone.
At E18, GABA B R2 immunoreactivity was strong in the neocortex (Fig. 2F±I) , and found in axons running in the lower intermediate zone, as well as in dendrites crossing the CP vertically (Fig. 2G±I ). The pyramidal cell layer in and above the SP was devoid of GABA B R2 immunoreactivity. In the VZ, GABA B R2 immunoreactivity was stronger than at earlier ages, especially in vertical processes located in the lower part, possibly related with radial glial cell processes (Fig 2G and I ).
Co-localization of GABA B R1 and GABA B R2
In order to investigate whether GABA B R1 and GABA B R2 were coexpressed in individual neurons during development, we carried out double-immuno¯uorescence experiments ( Fig. 3 ). At E16, we observed, in the cortical MZ, that around 95% of the cells immunoreactive for GABA B R2 were also labelled for GABA B R1 (Fig. 3) , resembling pioneer neurons of the MZ (Meyer et al., 1998) and SP neurons. The tangentially migratory cells located in the intermediate zone immunoreactive for GABA B R1, were not labelled for GABA B R2 (Fig. 3B , also see Fig. 1G ).
Characterization of neurons expressing GABA B Rs
In order to establish which neuronal populations express GABA B R1 at early stages of development, we carried out double-immunouorescence experiments for the receptor and for speci®c neuronal markers using confocal microscopy. We used PSA-NCAM (Fig. 4B) , a speci®c protein of tangentially migratory neurons in the cortical primordium (Seki & Arai, 1991) ; calbindin (CB, Fig. 4E ), a speci®c protein expressed in interneurons at early stages of development (Anderson et al., 1997) ; and Reelin (Fig. 4H) , an extracellular matrix glycoprotein that is synthesized and secreted by Cajal-Retzius cells (D'Arcangelo et al., 1995) .
We observed an intense labelling for PSA-NCAM in cells located in the intermediate zone, SP and MZ (Fig. 4B) , displaying the morphology of tangentially migrating neurons. A quantitative survey showed that around 97% of the cells immunopositive for PSA-NCAM in the MZ and intermediate zone also showed GABA B R1 immunoreactivity (Fig. 4C) , suggesting that the receptor was expressed in the majority of the tangentially migratory cells. However, not all cells with GABA B R1 immunoreactivity also expressed PSA-NCAM, indicating that the receptor might be also present in a population of nonmigratory neurons.
Using a monoclonal antibody against calbindin, we found intense labelling in cells located in the cortical MZ, corresponding to large rounded cells (Fig. 4E) , resembling pioneer neurons. Quantitative studies showed that at least 83% of those cells also showed GABA B R1 immunoreactivity.
Finally, in order to investigate whether the horizontal neurons expressing GABA B R1 in the cortical layer I were Cajal-Retzius cells, we used Reelin (Fig. 4H) . In prenatal animals, we did not detect colocalization of GABA B R1 and Reelin. However, in postnatal animals (P2), the estimate of colocalization showed a 97% overlap for GABA B R1-and Reelin-immunoreactivity in cortical layer I cells (Fig. 4I) , suggesting that the neurons expressing GABA B R1 are indeed Cajal-Retzius cells.
Expression of GABA B Rs during postnatal development
To study the tissue expression of GABA B Rs during postnatal development we carried out pre-embedding immunohistochemical studies at different ages up to adulthood. 
GABA B R1
At birth, we found high expression levels in all layers of the neocortex (Fig. 5A) . Thus, GABA B R1 immunoreactivity was detected mainly in cortical layer I neurons (Fig. 6B) having the typical fusiform morphology and horizontal orientation of Cajal-Retzius cells. In supragranular layers, GABA B R1 was observed in vertical processes most likely corresponding to the apical dendrites of layers IV±V pyramidal cells (Fig. 5A ). This characteristic pattern of distribution changed during development. Thus, at around P7, we observed strong labelling in somata ( Fig. 5C and F) and apical dendrites (Fig. 5E ) of layer V pyramidal cells, and in layer VIb cells (Fig. 5A, F, I and N) .
At P7, GABA B R1 immunolabelling was found in interneurons of supragranular layers, most of them located between layers I and II/III (Fig. 5D and G) . GABA B R1 immunolabelling was still found in putative Cajal-Retzius cells (Fig. 5D ), though at P10 the number of those neurons decreased (Fig. 5G ) and disappeared shortly after that age. GABA B R1 immunoreactivity was also observed in layer V pyramidal cells and their apical dendrites (Fig. 5C, E and F) .
At P15, the strong GABA B R1 labelling of pyramidal cell somata and apical dendrites decreased dramatically, while an intense neuropilar staining appeared in all cortical layers, especially in layer V (Fig. 5I ). In addition, we also observed many GABA B R1-immunoreactive interneurons with multipolar and bipolar ( Fig. 5I and J) morphology distributed throughout all cortical layers (Fig. 5J) .
At P21±P30, the adult levels of GABA B R1 immunoreactivity in the neocortex were reached. Immunolabelling was intense in the neuropil of layers I, II/III and V (Fig. 5L) , as well as a large proportion of immunoreactive interneuron somata and dendritic processes throughout all cortical layers (Fig. 5M) .
GABA B R2
During postnatal ages, we also observed a high expression of GABA B R2 in the neocortex. At P2, we found an intense GABA B R2 immunolabelling in most cortical layers ( Fig. 6A and B) , and particularly strong in the neuropil of layer I (Fig. 6B) . In supragranular layers, GABA B R2 was detected in vertical processes, probably apical dendrites of infragranular pyramidal cells (Fig. 6B) , though this characteristic pattern of distribution changed during development (Fig. 6) . Thus, at P7 and P10, the strongest neuropilar staining was detected in layer I (Fig. 6C and D) , but from P15 onwards, all layers reached similar levels of GABA B R2 immunoreactivity ( Fig. 6E and  F) . We did not detect immunoreactive somata of pyramidal cells or interneurons in any layer at any developmental age.
Subcellular localization of GABA B Rs during pre-and postnatal development
To investigate the precise subcellular localization of GABA B R1 and GABA B R2 during pre-and postnatal development we carried out electron microscopic investigations using the pre-embedding immunoperoxidase and immunogold techniques.
GABA B R1
During prenatal development we concentrated on the SP and CP, where the intensity of immunostaining at E18 was the strongest. GABA B R1 immunoreactivity was found postsynaptically in SP cells with an elongated morphology and only one dendritic process (Fig. 7) running parallel to the pial surface. In all the cases, the peroxidase reaction end-product was observed forming patches and associated with the plasma membrane ( Fig. 7A and B) or intracellular organelles ( Fig. 7C and D) .
During postnatal development, GABA B R1 immunoreactivity was associated to the plasma membrane and the endoplasmic reticulum (Fig. 8A±C ) of layer I cells with an ultrastructure resembling that of Cajal-Retzius cells (Fig. 8A) . Strong GABA B R1 immunoreactivity was also found in the somata (Fig. 8D ) and dendritic trees (Fig. 8D±  F) of a subset of interneurons in all layers of the neocortex, invariably associated with the plasma membrane and intracellular organelles. Peroxidase reaction end-product for GABA B R1 ®lled dendritic spines of pyramidal cells throughout all cortical layers ( Fig. 8G and H) . The dendritic shafts of pyramidal cells were also immunolabelled, but the density of the reaction product was consistently lower than that observed within the spines.
Finally, we also observed GABA B R1 immunoreactivity in presynaptic elements, distributed throughout all cortical layers and postnatal ages (Fig. 8I and J) . Peroxidase reaction end-product ®lled axon terminals establishing asymmetrical synapses (e.g., see Fig. 8I ). A few immunolabelled symmetrical synaptic contacts were also observed. Immunoparticles were also found on axonal membranes and occasionally at the presynaptic active zone of putative glutamatergic synapses (Fig. 8K) .
GABA B R2
The distribution of GABA B R2 immunoreactivity in the neocortex during postnatal development was almost identical to the distribution of GABA B R1. Thus, peroxidase reaction end-product for GABA B R2 ®lled dendritic spines and dendritic shafts of pyramidal cells (Fig. 9A±G) . Immunoreactive dendrites established asymmetrical synaptic contacts with putative glutamatergic axon terminals (Fig. 9A, D, E and G) . Immunoparticles were mostly detected on the extrasynaptic plasma membrane of pyramidal cells spines (Fig. 9H and G) and also at the edge of asymmetrical synapses (Fig. 9I) . GABA B R2 immunoreactivity was also detected in presynaptic elements throughout development (Fig. 9B and F) . Immunoparticles were located on axonal membranes, as well as at the presynaptic active zone of putative glutamatergic synapses (Fig. 9J) .
Discussion
The present study provides the ®rst detailed description of the expression pattern, and precise cellular and subcellular localization of GABA B R in the rat neocortex during prenatal and postnatal development. Using conventional light and confocal microscopy we have shown that GABA B R1 and GABA B R2 are expressed from very early stages of cortical development and are widely distributed in the neocortex during development in pyramidal and nonpyramidal cells. The colocalization of the two receptor subtypes in the same embryonic cortical cells suggests that GABA B R form heteromeric complexes and that these cells express functional GABA B R from very early stages of development. Furthermore, immunoelectron microscopy revealed an association of GABA B R1 and GABA B R2 with putative glutamatergic synapses and demonstrated their postsynaptic and presynaptic localization in the neocortex during development. The similar subcellular localization of the two receptor subtypes suggest that during cortical morphogenesis, functional GABA B R expressed in different neuronal compartments may play an important role in maturation and cortical organization events.
Expression of GABA B Rs in embryonic cortical cells
GABA B R1 and GABA B R2 were expressed from very early stages of neocortical development, though they differed mainly in the intensity of immunolabelling within the same brain areas. This early presence of GABA B R in the neocortex is in line with a recent study showing that embryonic cortical cells contain mRNA and protein for GABA B R1, and that this receptor subtype is functional at E17 in both cortical plate and ventricular zone cells (Behar et al., 2001) . Our data further demonstrated that GABA B R1 is expressed in cortical plate cells even earlier, at E14, and showed that it is present in the tangentially migratory interneurons coming from the medial ganglionic eminence.
Previous in vitro studies, using neurons dissociated from immature cortical regions, demonstrated that GABA could act as a chemoattractant, stimulating embryonic nerve cell movement (Behar et al., 1996 (Behar et al., , 1998 . The same authors reported that GABA released by cortical cells stimulates postmitotic layer II/III cells to migrate radially into the cortical plate via activation of saclofen-and picrotoxin-sensitive receptors (Behar et al., 2000) . Taken together, these and our results suggest that both routes of neuronal migration, radial and tangential, might be modulated via activation of GABA B R.
Our immunohistochemical studies have indicated that a majority of MZ and CP cells coexpress GABA B R1 and GABA B R2 during prenatal development. It has been suggested that the coassembly of GABA B R1 and GABA B R2 subtypes into heteromeric complexes is required for the translocation of the receptor from the synthetic site to the cell surface (Margeta-Mitrovic et al., 2000) and also for agonistinduced signalling (Couve et al., 1998; Jones et al., 1998; Kaupmann et al., 1998a; White et al., 1998; Kuner et al., 1999) . Furthermore, colocalization of GABA B R1 and GABA B R2 has been observed in the CNS (Kaupmann et al., 1998a; Billinton et al., 2000; Gonchar et al., 2001; Kulik et al., 2002) in adult animals. However, no colocalization has been demonstrated in embryonic cortical cells yet. Therefore, our ®nding, that both GABA B R subtypes are expressed in the MZ and CP cells, suggests that membrane-bound GABA B R are functionally active at an early stage of neuronal development.
In the neocortex, the precise functional signi®cance of GABA B R during development remains unclear. Obrietan & van den Pol (1998 postulated that in embryonic cells, GABA B R play a crucial inhibitory role regulating Ca 2+ rises elicited by GABA A activation and/or by inhibiting glutamate receptor-mediated Ca 2+ transients. Alterations in intracellular Ca 2+ are involved in many processes essential for neuronal development, such as growth cone motility, neurite outgrowth, neuronal migration and synapse formation (Komuro & Rakic, 1996; Mattson & Kater, 1987; Nelson et al., 1990) . Our ®nding of abundant GABA B R1 and GABA B R2 immunoreactivity in the embryonic cortex supports a potentially important role for GABA B R in a wide array of physiological processes during corticogenesis.
Developmental distribution of GABA B Rs
The immunohistochemical distribution pattern of GABA B R1 and GABA B R2 in the neocortex is consistent with earlier in situ hybridization (Kaupmann et al., 1998a; Bischoff et al., 1999; Durkin et al., 1999; Clark et al., 2000) and autoradiographic studies (Bowery et al., 1987; Chu et al., 1990; Turgeon & Albin, 1994) .
GABA B R1, but not GABA B R2, was observed in Cajal-Retzius cells and the tangential migratory cells during prenatal development. Physiological responses following activation of GABA B R require the coassembly of GABA B R1 and GABA B R2 (Jones et al., 1998; Kaupmann et al., 1998b; White et al., 1998; Kuner et al., 1999) . The possible expression of homomeric GABA B R1 by Cajal-Retzius cells and the tangential migratory cells in the lower intermediate zone (LIZ) suggests either that they are nonfunctional GABA B R or that additional subtypes or isoforms of GABA B R and/or other proteins exist that have not yet been identi®ed. The absence of functional coupling to postsynaptic ion channels (White et al., 1998; Martin et al., 1999) is supported by our preliminary electrophysiological data on Cajal-Retzius cells that revealed no activation of outward current after application of baclofen (G. Lo Âpez-Bendito, R. Luja Ân and O. Paulsen, unpublished observations). Overall, the spatiotemporal expression of GABA B R1 reported here in the MZ/layer I may be an important mechanism to regulate Ca 2+ dynamics, which is thought to play a role in the regulation of gene expression and control of developmental events.
Interestingly, GABA B R1 showed a developmental reorganization in cortical pyramidal cells peaking around P10. Thus, during the ®rst postnatal week, GABA B R1 was located preferentially in pyramidal cell somata and dendrites projecting to layer I. At P10±P15, the receptor became more uniformly distributed on the surface of the pyramidal cells, though mainly localized in dendritic spines and associated with synapses. A similar redistribution has also been described for group I mGluRs in the same neocortical cell types during development (Lo Âpez-Bendito et al., 2002) . Interneurons expressed GABA B R during development in the neocortex, with the staining for GABA B R1 being present in somata and extending uniformly throughout the dendritic arbour. However, although at light microscopic level the staining for GABA B R2 was not detected in cell bodies of interneurons, electron microscopy showed that they expressed this subtype indeed. The GABA B R1-containing interneurons showed different morphology and location throughout the neocortex, suggesting the existence of different subset of interneurons expressing GABA B R. This is in agreement with ®ndings of Gonchar et al. (2001) cortex (Gonchar et al., 2001) . Those studies showed that GABA B R1 and GABA B R2 were found at extrasynaptic sites, at the edges of asymmetrical synapses and occasionally over the synaptic membrane specialization. Our ®nding that a high proportion of dendritic spines of cortical pyramidal cells were immunoreactive for both GABA B R1 and GABA B R2 is consistent with previous studies ( directly demonstrated that pyramidal cells and interneurons contained both postsynaptic and presynaptic GABA B R.
Several studies have shown that baclofen suppressed evoked excitatory postsynaptic potentials (EPSPs) and IPSPs, suggesting that GABA B R mediate presynaptic inhibition of excitatory and inhibitory neurotransmission in different brain regions (Pittaluga et al., 1987; Brugger et al., 1993) . In the neocortex, we found GABA B R1 and GABA B R2 in axon terminals establishing asymmetrical synapses during cortical development. This ®nding is consistent with electrophysiological studies that showed depression of excitatory responses by GABA B R agonist in neocortex (Howe et al., 1987; Deisz et al., 1997; Varela et al., 1997) .
The association of GABA B R with asymmetrical synapses, presumably glutamatergic, in adult and during development raises the question of what is the source of GABA to activate these receptors. One possible source of GABA to activate GABA B R is the spillover from neighbouring interneurons (Isaacson et al., 1993) . Another possibility is the activation through taurine, a weak agonist at GABA B R. Taurine is present in the cortex and has been suggested to act as a chemoattractant for neurons during cortical development via mechanisms involving GABA B R (Behar et al., 2001) . Finally, GABA B R may be activated by nonsynaptically released GABA. In the neocortex, this mechanism of activation has recently been suggested for presynaptic GABA B R on pyramidal cell axon terminals (Zilberter et al., 1999) . Regardless of the mechanism of activation of GABA B R, the colocalization of GABA B R1 and GABA B R2 at excitatory synapses suggests that they are functional and it is likely that they are involved in developmental physiological events.
